Defining your manufacturing strategy can be a complex task with many variables impacting the outcome. Our team of experienced consultants can help you with various aspects of your strategy planning.

We can help you in the assessment of your current manufacturing process to help identify possible improvements and define a process development strategy.

eXmoor offers a range of process and analytical development services targeted at improving the commercialisation of cell and gene therapy products.

When the build or buy decision has been made in favour of a capital project expansion, eXmoor helps with the critical early phases of a capital project.

We have extensive experience in specification, design, commissioning and qualification gained in the pharma, biotech, cell and gene therapy industries.

Our QP’s provide GMP Compliance support across all of eXmoor’s client portfolio, are experienced in being able to interpret regulatory guidance requirements and apply this to our clients’ needs.

Our QPs combine experience across both operational and capital projects making them suited to be named on your license as QP.

From cryopreserved and frozen cell therapy product to filled syringe ready for administration.